Two-injection start regimen of long-acting aripiprazole for bipolar disorder

Tips and tricks for better efficacy and tolerability

Bibliographic Data

ID15528775
AuthorsGülçin Elboğa (0000-0003-3903-1835, Gaziantep University, corresponding author), Irem Surme (Kayseri Eğitim ve Araştırma Hastanesi), Muhammet Sancaktar (0000-0002-4209-2885, Gaziantep University), Bahadır Demir (0000-0003-2798-6255, Gaziantep University), Şengül Kocamer Şahin (0000-0002-5371-3907, University of Health Sciences Antigua), Abdurrahman Altindag (Gaziantep University)
Year2026
Volume16
Pages1627052-1627052
Publication date2026-01-23
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2025.1627052
PMID41659176
OpenAlexW7125482536
LanguageEN
References cited25

This study highlights the efficacy and reliability of the TIS regimen in treating BD episodes, potentially facilitating faster clinical recovery by reducing the need for prolonged oral supplementation

Aripiprazole · Clinical efficacy · Clinical trial · Context (archaeology · Regimen · Tolerability · Bipolar Disorder and Treatment · Obsessive-Compulsive Spectrum Disorders · Schizophrenia research and treatment

Tools

Open DOIOpen Access